SCHEMBL784944

SCHEMBL784944

CCN(C(=O)c1ccc(F)cc1Cl)C1CCc2ccc(C(=O)O)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
ADORA2A P29274 1/20 0.42
TRPM8 Q7Z2W7 2/20 0.41
PYGL P06737 4/20 0.39
KDM4A O75164 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.37
DRD3 P35462 1/20 0.37
HSD11B1 P28845 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 1/20 0.36
MDM4 O15151 1/20 0.34
MDM2 Q00987 1/20 0.34
HTR2C P28335 1/20 0.34
KCNH2 Q12809 1/20 0.34
MCHR1 Q99705 1/20 0.34
PDK2 Q15119 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL786012 1.00 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3ADORA2ATRPM8
SCHEMBL784507 0.92 TRPM8 (0.41) SLC6A2SLC6A4SLC6A3ADORA2ATRPM8
SCHEMBL784506 0.92 TRPM8 (0.41) SLC6A2SLC6A4SLC6A3ADORA2ATRPM8
SCHEMBL803201 0.89 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3ADORA2ATRPM8
SCHEMBL785078 0.88 TRPM8 (0.43) SLC6A2SLC6A4SLC6A3TRPM8PYGL
SCHEMBL785630 0.88 TRPM8 (0.43) SLC6A2SLC6A4SLC6A3TRPM8PYGL
SCHEMBL785978 0.87 TP53 (0.43) SLC6A2SLC6A4SLC6A3TRPM8PYGL
SCHEMBL785167 0.87 TP53 (0.43) SLC6A2SLC6A4SLC6A3TRPM8PYGL
SCHEMBL785536 0.84 TRPM8 (0.47) SLC6A2SLC6A4SLC6A3TRPM8PYGL
SCHEMBL803766 0.84 TRPM8 (0.47) SLC6A2SLC6A4SLC6A3TRPM8PYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 SLC6A2 1966/4885SLC6A4 1682/4885SLC6A3 1597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.